China-based Innoforce Pharmaceuticals raises $96m in Series A round

Innoforce Pharmaceuticals, a Chinese biopharmaceutical innovation and partnership company, has raised CNY625 million ($96 million) in a Series A financing round. The Series A round ... Read More